Review



mtor total  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Cell Signaling Technology Inc mtor total
    Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit <t>1;</t> <t>GATOR1/2,</t> GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and <t>mTOR</t> activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .
    Mtor Total, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 8593 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/mTOR+Antibody/pmc12975357-114-49-54
    Average 97 stars, based on 8593 article reviews
    mtor total - by Bioz Stars, 2026-11
    97/100 stars

    Images

    1) Product Images from "Amino Acid Signaling in Skeletal Muscle Is Blunted by Prematurity in a Piglet Model"

    Article Title: Amino Acid Signaling in Skeletal Muscle Is Blunted by Prematurity in a Piglet Model

    Journal: The Journal of Nutrition

    doi: 10.1016/j.tjnut.2025.101303

    Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit 1; GATOR1/2, GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and mTOR activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .
    Figure Legend Snippet: Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit 1; GATOR1/2, GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and mTOR activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .

    Techniques Used: Activity Assay, Binding Assay

    Related Articles

    Incubation:

    Article Title: Non-redundant functions of insulin/FOXO and EcR signaling pathways regulate accessory gland structure, function and male fertility in Drosophila.
    Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article.

    Article Title: Targeting FOXA1 with repurposed tigecycline to overcome therapeutic resistance in castration-resistant prostate cancer
    Article Snippet: .. After blocking with 5% non-fat milk in PBS 159 for 1 h at room temperature, the membranes were incubated overnight at 4 °C with the 160 following primary antibodies: FOXA1 (Abcam, #ab23738, 1:1000); GAPDH 161 (Proteintech, # 60004-1-Ig, 1:10000); CCNA2 (Zenbio, #R27473, 1:500); UBE2C 162 (Zenbio, #R27398, 1:500); CDK1 (Proteintech, #19532-1-AP, 1:2000); PSA (Santa 163 Cruz, #sc-7316, 1:200); AR (Proteintech, #22089-1-AP, 1:5000); β-Actin (Proteintech, 164 #20536-1-AP, 1:5000); NKX3.1 (Zenbio, #R382345, 1:1000); flag (Proteintech, 165 #66008-4-Ig, 1:5000); FOXA1 (CST, #53528, 1:1000); ERK2 (Zenbio, #R22846, 166 1:1000); Phospho-AKT1 (Zenbio, #310021, 1:1000); Phospho-S6 (CST, #4858, 167 1:2000); S6 (CST, #2217, 1:1000); H3 (CST, #9715, 1:1000); 4EBP1 (CST, #9644, 168 1:1000); Phospho-4EBP1 (CST, #2855, 1:1000); mTOR (CST, #2972, 1:1000); 169 Phospho-mTOR (CST, #2971, 1:1000). ..

    Article Title: Metformin (DMBG) ameliorates diabetic erectile dysfunction via the AMPK/mTOR pathway in association with endothelial autophagy reactivation.
    Article Snippet: Background: Diabetes mellitus erectile dysfunction (DMED) is a prevalent complication with limited treatment efficacy.. Metformin (dimethylbiguanide, DMBG) shows therapeutic potential, but its underlying mechanisms remain unclear.. This study investigated whether DMBG alleviates DMED in association with restored endothelial

    Article Title: Madecassic acid attenuates sepsis-associated acute lung injury by regulating the PI3K/AKT/mTOR pathway to mediate anti-inflammatory, antioxidant and anti-apoptotic effects
    Article Snippet: .. The membranes were then incubated with the corresponding primary antibodies: Bax (2772, CST), Bcl2 (3498, CST), cleaved caspase-3 (9661, CST), p-PI3K (4228, CST), PI3K (4292, CST), p-AKT (4060, CST), AKT (9272, CST), p-mTOR (2971, CST), mTOR (2972, CST) and GAPDH (2118, CST). ..

    Blocking Assay:

    Article Title: Targeting FOXA1 with repurposed tigecycline to overcome therapeutic resistance in castration-resistant prostate cancer
    Article Snippet: .. After blocking with 5% non-fat milk in PBS 159 for 1 h at room temperature, the membranes were incubated overnight at 4 °C with the 160 following primary antibodies: FOXA1 (Abcam, #ab23738, 1:1000); GAPDH 161 (Proteintech, # 60004-1-Ig, 1:10000); CCNA2 (Zenbio, #R27473, 1:500); UBE2C 162 (Zenbio, #R27398, 1:500); CDK1 (Proteintech, #19532-1-AP, 1:2000); PSA (Santa 163 Cruz, #sc-7316, 1:200); AR (Proteintech, #22089-1-AP, 1:5000); β-Actin (Proteintech, 164 #20536-1-AP, 1:5000); NKX3.1 (Zenbio, #R382345, 1:1000); flag (Proteintech, 165 #66008-4-Ig, 1:5000); FOXA1 (CST, #53528, 1:1000); ERK2 (Zenbio, #R22846, 166 1:1000); Phospho-AKT1 (Zenbio, #310021, 1:1000); Phospho-S6 (CST, #4858, 167 1:2000); S6 (CST, #2217, 1:1000); H3 (CST, #9715, 1:1000); 4EBP1 (CST, #9644, 168 1:1000); Phospho-4EBP1 (CST, #2855, 1:1000); mTOR (CST, #2972, 1:1000); 169 Phospho-mTOR (CST, #2971, 1:1000). ..

    Article Title: Metformin (DMBG) ameliorates diabetic erectile dysfunction via the AMPK/mTOR pathway in association with endothelial autophagy reactivation.
    Article Snippet: Background: Diabetes mellitus erectile dysfunction (DMED) is a prevalent complication with limited treatment efficacy.. Metformin (dimethylbiguanide, DMBG) shows therapeutic potential, but its underlying mechanisms remain unclear.. This study investigated whether DMBG alleviates DMED in association with restored endothelial



    Similar Products

    96
    Proteintech total mtor
    Total Mtor, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/mTOR+Antibody/pm42571819-78-36-39
    Average 96 stars, based on 1 article reviews
    total mtor - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc mtor total
    Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit <t>1;</t> <t>GATOR1/2,</t> GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and <t>mTOR</t> activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .
    Mtor Total, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/mTOR+Antibody/pmc12975357-114-49-54
    Average 97 stars, based on 1 article reviews
    mtor total - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti total mtor
    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated <t>mTOR</t> (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Anti Total Mtor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/mTOR+Rabbit+mAb/pmc12757582-422-15-17
    Average 97 stars, based on 1 article reviews
    anti total mtor - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc total mtor
    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated <t>mTOR</t> (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Total Mtor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/pmc12539926__ehaf324_supplementary_data-46-9-13
    Average 86 stars, based on 1 article reviews
    total mtor - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc polyclonal rabbit anti total mtor
    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated <t>mTOR</t> (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Polyclonal Rabbit Anti Total Mtor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/pmc12597599-36-0-3
    Average 86 stars, based on 1 article reviews
    polyclonal rabbit anti total mtor - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology antibodies against fibronectin, claudin-1, upa, mt1-mmp, cleaved caspase-3, phospho-mtor, total mtor, and phospho-akt
    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated <t>mTOR</t> (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Antibodies Against Fibronectin, Claudin 1, Upa, Mt1 Mmp, Cleaved Caspase 3, Phospho Mtor, Total Mtor, And Phospho Akt, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/antibodies+against+fibronectin++claudin+1++upa++mt1+mmp++cleaved+caspase+3++phospho+mtor++total+mtor++and+phospho+akt/pm40643514-50-35-39
    Average 90 stars, based on 1 article reviews
    antibodies against fibronectin, claudin-1, upa, mt1-mmp, cleaved caspase-3, phospho-mtor, total mtor, and phospho-akt - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc antibodies against total mtor
    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated <t>mTOR</t> (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Antibodies Against Total Mtor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+mtor/anti+mtor/pm40593047-42-4-17
    Average 90 stars, based on 1 article reviews
    antibodies against total mtor - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit 1; GATOR1/2, GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and mTOR activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .

    Journal: The Journal of Nutrition

    Article Title: Amino Acid Signaling in Skeletal Muscle Is Blunted by Prematurity in a Piglet Model

    doi: 10.1016/j.tjnut.2025.101303

    Figure Lengend Snippet: Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit 1; GATOR1/2, GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and mTOR activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .

    Article Snippet: Immunoblotting and immunoprecipitation assays were performed using the following primary antibodies: ARF1 (Cat. No. 68069-1-AP; ProteinTech Group), CASTOR1/GATSL3 (Cat. No. A13309; Boster Biological Technology), LARS (Cat. No. A304-316A; Bethyl Laboratories), Mios, a GATOR2 subunit (Cat. No. 13557; Cell Signaling Technology), mTOR phosphorylated Ser2448 (Cat. No. 2971; Cell Signaling Technology), mTOR total (Cat. No. 2972; Cell Signaling Technology), NPRL2, a GATOR1 subunit (Cat. No. 37344, 37344; Cell Signaling Technology), Rab1A (Cat. No. 13075; Cell Signaling Technology), RagA (Cat. No. 4357; Cell Signaling Technology), RagC (Cat. No. 9480; Cell Signaling Technology), Raptor (Cat. No. 2280; Cell Signaling Technology), SAMTOR/BMT2 (Cat. No. 21744-1-AP; ProteinTech Group), SAR1B (Cat. No. 22292-1-AP; ProteinTech Group), Sestrin1 (Cat. No. 55010-1-AP; ProteinTech Group), Sestrin2 (Cat. No. 66297-1-Ig; ProteinTech Group), SLC38A2/sodium-coupled neutral amino acid transporter (SNAT)2 (Cat. No. ARP33059_P050; Aviva Systems Biology), SLC38A9 (Cat. No. AAS59532C; Antibody Verify), LAT/1SLC7A5 (Cat. No. BMP011; MBL International), and TARS2 (Cat. No. 15067-1-AP; ProteinTech Group).

    Techniques: Activity Assay, Binding Assay

    AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated mTOR (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: The ionotropic AMPA receptor contributes to autoimmunity via altered regulatory T cell differentiation

    doi: 10.1016/j.isci.2025.114267

    Figure Lengend Snippet: AMPAR-deficient CD4 T cells changed cytokine sensitivity and metabolically shifted toward glycolysis and lipid metabolism (A) Quantification of Foxp3 gMFI flow staining of WT and T ΔAMPAR iTregs cultured under the titration of IL-2 (mean ± SEM, ANOVA, representative of 3 independent experiments). (B) Representative flow plot of pSTAT5 + Foxp3 + expression (left) and quantification (right) from WT and T ΔAMPAR iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). (C) Quantification of CD4 + CD25 + frequency over the course of iTreg differentiation (mean ± SEM, ANOVA, representative of 3 independent experiments). (D) Western blot of WT and T ΔAMPAR CD4 T cells collected on day 1, 2, and 3 of iTreg differentiation, immunoblotted for phosphorylated mTOR (pmTOR), total mTOR, and β-Actin expression (top to bottom, representative of 3 independent experiments). (E) Quantification of CD71 + cells among CD4 + T cells on day 3 of iTreg differentiation. (mean ± SEM, t test, representative of 3 independent experiments). (F–I) Seahorse metabolic flux analysis of iTreg cells. (F) extracellular acidification rate (ECAR) measurement over time (minutes) and (G) quantification of glycolysis (left) and glycolytic capacity (right) measurements. (H) oxygen consumption rate (OCR) measurement over time (minutes) and (I) quantification of maximum respiratory capacity (left) and reserve capacity (right) measurements (mean ± SEM, ANOVA, representative of 3 independent experiments). (J and K) WT and T ΔAMPAR CD4 were cultured under iTreg polarizing conditions and subjected to bulk RNA sequencing and analysis. (J) GSEA plot of cholesterol metabolism pathway enrichment in T ΔAMPAR versus WT cells. (K) Heatmap of genes associated with cholesterol metabolism in T ΔAMPAR versus WT. (L) Quantification of Srebf1 , Srebf2 , Hmgcr , Acaca , Fasn , and Sqle mRNA relative expression in WT and T ΔAMPAR CD4 from iTreg culture determined by qPCR (mean ± SEM, ANOVA, representative of 2 independent experiments). (M) Western blot images (left) of WT and T ΔAMPAR immunoblotted for Srebf1 and Srebf2 (image is representative of 2 independent experiments) and quantification (right) of cleaved to precursor ratios analyzed by densitometry. (N and O) Cell staining for Lipid and cholesterol content. (N) Bodipy and (O) Filipin III gMFI flow staining of WT and T ΔAMPAR CD4 from day 2 iTreg cultures (mean ± SEM, t test, representative of 3 independent experiments). Statistical significance represented as ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Article Snippet: Probes included: anti-pSMAD3 (Cell signaling, 9520), anti-total SMAD2/3 (Cell signaling, 3102), anti-pmTOR (Cell signaling, 2971), anti-total mTOR (Cell signaling, 2983), anti-Srebp1 (Abcam, ab3259), anti-Srebp2 (Abcam, ab30682), anti-β-tubulin (Cell signaling, 86298) and anti-β-actin (Cell signaling, 4970).

    Techniques: Metabolic Labelling, Staining, Cell Culture, Titration, Expressing, Western Blot, RNA Sequencing